Interestingly, in the present study cohort, the use of anti-hypertensive medications was negatively associated with circulating IL32, and treatment with ACE-I and beta-blockers was associated not only with improved blood pressure control in participants with hypertension, but also with lower levels of IL32. The gene discussed is IL32; the disease is hypertensive disorder.